H.-J. Möller

558 total citations
26 papers, 340 citations indexed

About

H.-J. Möller is a scholar working on Psychiatry and Mental health, Pharmacology and Experimental and Cognitive Psychology. According to data from OpenAlex, H.-J. Möller has authored 26 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 6 papers in Pharmacology and 5 papers in Experimental and Cognitive Psychology. Recurrent topics in H.-J. Möller's work include Treatment of Major Depression (6 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (5 papers) and Bipolar Disorder and Treatment (5 papers). H.-J. Möller is often cited by papers focused on Treatment of Major Depression (6 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (5 papers) and Bipolar Disorder and Treatment (5 papers). H.-J. Möller collaborates with scholars based in Germany, Austria and Slovenia. H.-J. Möller's co-authors include Harald Hampel, B. Ljunggren, Siegfried Kasper, K. Glaser, Charles L. Bowden, Heinz Grunze, Eduard Vieta, Rasmus Wentzer Licht, Friedhelm Leverkus and Claus Göbel and has published in prestigious journals such as Schizophrenia Research, Dementia and Geriatric Cognitive Disorders and European Neuropsychopharmacology.

In The Last Decade

H.-J. Möller

25 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H.-J. Möller Germany 10 178 95 61 43 42 26 340
Neil M. Kurtz United States 11 189 1.1× 74 0.8× 38 0.6× 39 0.9× 46 1.1× 18 393
Stephen T.H. Sokolov Canada 11 149 0.8× 172 1.8× 56 0.9× 31 0.7× 50 1.2× 13 370
Céline Goldberger France 9 145 0.8× 66 0.7× 22 0.4× 59 1.4× 70 1.7× 19 335
Kazuto Oya Japan 11 205 1.2× 106 1.1× 35 0.6× 66 1.5× 45 1.1× 15 462
D Bobon Belgium 10 131 0.7× 76 0.8× 33 0.5× 68 1.6× 30 0.7× 38 300
Philippe Bouhours France 11 329 1.8× 131 1.4× 74 1.2× 23 0.5× 75 1.8× 20 481
Yuen Mei See Singapore 8 192 1.1× 102 1.1× 47 0.8× 21 0.5× 102 2.4× 17 369
H. Gerbaldo Germany 10 152 0.9× 57 0.6× 34 0.6× 82 1.9× 47 1.1× 21 407
Kenneth B. Kashkin United States 6 239 1.3× 125 1.3× 28 0.5× 87 2.0× 20 0.5× 8 524
Yu-Ping Ning China 13 201 1.1× 61 0.6× 59 1.0× 60 1.4× 74 1.8× 22 431

Countries citing papers authored by H.-J. Möller

Since Specialization
Citations

This map shows the geographic impact of H.-J. Möller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.-J. Möller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.-J. Möller more than expected).

Fields of papers citing papers by H.-J. Möller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.-J. Möller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.-J. Möller. The network helps show where H.-J. Möller may publish in the future.

Co-authorship network of co-authors of H.-J. Möller

This figure shows the co-authorship network connecting the top 25 collaborators of H.-J. Möller. A scholar is included among the top collaborators of H.-J. Möller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.-J. Möller. H.-J. Möller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schennach-Wolff, Rebecca, H.-J. Möller, Markus Jäger, et al.. (2010). A Critical Analysis and Discussion of the Appropriateness of the Schizophrenia Consensus Remission Criteria in Clinical Pharmaceutical Trials. Pharmacopsychiatry. 43(7). 245–251. 2 indexed citations
2.
Riedel, Michael, Ilja Spellmann, Rebecca Schennach-Wolff, et al.. (2009). Effect of Aripiprazole on Cognition in the Treatment of Patients with Schizophrenia. Pharmacopsychiatry. 43(2). 50–57. 34 indexed citations
3.
Riedel, Matthias, Florian Wickelmaier, Rebecca Schennach-Wolff, et al.. (2009). Häufigkeit und klinische Charakteristika von atypisch depressiven Symptomen. Nervenheilkunde. 28(4). 193–199. 1 indexed citations
4.
Zwanzger, Peter, Daniela Eser, Caroline Nothdurfter, et al.. (2009). Effects of the GABA-reuptake Inhibitor Tiagabine on Panic and Anxiety in Patients with Panic Disorder. Pharmacopsychiatry. 42(6). 266–269. 28 indexed citations
5.
Leinsinger, G., C. Born, Thomas Meindl, et al.. (2007). Age-Dependent Differences in Human Brain Activity Using a Face- and Location-Matching Task: An fMRI Study. Dementia and Geriatric Cognitive Disorders. 24(4). 235–246. 7 indexed citations
6.
Ruhrmann, Stephan, K.‐U. Kühn, Frauke Schultze‐Lutter, et al.. (2006). WC2G ACUTE SYMPTOMATIC TREATMENT EFFECTS IN PERSONS CLINICALLY AT RISK FOR PSYCHOSIS. Schizophrenia Research. 86. S8–S8. 5 indexed citations
7.
Jäger, Markus, et al.. (2003). Diagnoseverschiebungen der funktionellen Psychosen beim Übergang von der ICD-9 zur ICD-10. Der Nervenarzt. 74(5). 420–427. 2 indexed citations
8.
Grunze, Heinz, Siegfried Kasper, Gary W. Goodwin, et al.. (2002). Task Force on Treatment Guidelines for Bipolar Disorders. The World Journal of Biological Psychiatry. 115–124. 49 indexed citations
9.
Bottlender, Ronald, et al.. (2002). Neuroleptic Malignant Syndrome due to Atypical Neuroleptics: Three Episodes in One Patient. Pharmacopsychiatry. 35(3). 119–121. 17 indexed citations
10.
Winkler, Dietmar, N. Praschak-Rieder, Matthäus Willeit, et al.. (2002). Saisonal abhängige Depression in zwei deutschsprachigen Universitätszentren: Bonn, Wien Klinische und demographische Charakteristika. Der Nervenarzt. 73(7). 637–643. 13 indexed citations
11.
Möller, H.-J., K. Glaser, Friedhelm Leverkus, & Claus Göbel. (2000). Double-blind, Multicenter Comparative Study of Sertraline versus Amitriptyline in Outpatients with Major Depression. Pharmacopsychiatry. 33(6). 206–212. 22 indexed citations
12.
Bürger, Katharina, Stéphane Schück, H.-J. Möller, et al.. (2000). [Multiconceptual therapy in Alzheimer's disease].. PubMed. 29(21). 1197–201. 1 indexed citations
13.
Möller, H.-J.. (1999). Can negative symptoms of schizophrenia be partially or totally controlled by antipsychotics?. European Neuropsychopharmacology. 9. 135–136. 3 indexed citations
14.
Möller, H.-J., et al.. (1998). Opipramol bei Angst- und Somatisierungsstörungen. Fortschritte der Neurologie · Psychiatrie. 66(S 1). S21–S24. 4 indexed citations
15.
Möller, H.-J., Juergen Gallinat, Ulrich Hegerl, et al.. (1998). Double-Blind, Multicenter Comparative Study of Sertraline and Amitriptyline in Hospitalized Patients with Major Depression. Pharmacopsychiatry. 31(5). 170–177. 23 indexed citations
16.
Hampel, Harald, et al.. (1997). Blood-Cerebrospinal Fluid Barrier Dysfunction for High Molecular Weight Proteins in Alzheimer Disease and Major Depression. Alzheimer Disease & Associated Disorders. 11(2). 78–87. 50 indexed citations
17.
Möller, H.-J., et al.. (1995). A Controlled Study of the Efficacy and Safety of Mianserin and Amitriptyline in Depressive Inpatients. Pharmacopsychiatry. 28(6). 249–252. 9 indexed citations
18.
Kasper, Siegfried & H.-J. Möller. (1992). SEROTONIN RE-UPTAKE INHIBITORS AND SUICIDALITY. Clinical Neuropharmacology. 15. 36B–36B. 1 indexed citations
19.
Möller, H.-J. & Helen Mayer Hacker. (1988). Study concerning the Sample Dependency and Temporal Variance of the Factor Structure in the Inpatient Multidimensional Psychiatric Scale. Psychopathology. 21(6). 281–290. 2 indexed citations
20.
Ljunggren, B. & H.-J. Möller. (1977). Phenothiazine phototoxicity: an experimental study on chlorpromazine and related tricyclic drugs. Acta Dermato Venereologica. 57(4). 325–329. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Neil M. Kurtz Breakdown of academic impact, for papers by Stephen T.H. Sokolov Breakdown of academic impact, for papers by Céline Goldberger Breakdown of academic impact, for papers by Kazuto Oya Breakdown of academic impact, for papers by D Bobon Breakdown of academic impact, for papers by Philippe Bouhours Breakdown of academic impact, for papers by Yuen Mei See Breakdown of academic impact, for papers by H. Gerbaldo Breakdown of academic impact, for papers by Kenneth B. Kashkin Breakdown of academic impact, for papers by Yu-Ping Ning
Rankless by CCL
2026